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In general, T H 2-mediated asthma can be well treated by corticosteroid inhalation, whereas patients with T H 17-mediated neutrophilic asthma are often unresponsive to corticosteroid treatment, resulting in poor disease control and frequent exacerbations. 2 Myeloid cells, such as macrophages, monocytes, and dendritic cells (DCs), have antigen-presenting functions and control naive CD4
1 T-cell differentiation into effector T H 2 and T H 17 cells in the setting of asthma but also mediate tolerance to inhaled antigens. 3, 4 T H cell differentiation depends on antigen dosing, expression of costimulatory molecules, and the cytokine milieu. T H 2 cell differentiation is favored with a low antigen dose 5, 6 and expression of OX40 ligand and Jagged on antigenpresenting cells [7] [8] [9] [10] in a cytokine environment high in IL-4 and low in IL-12. 11 Conversely, T H 17 cell differentiation is induced by a high antigen dose, 12 expression of CD40 and CD86, 13 and an IL-1b-, IL-6-, and TGF-b-rich environment.
14 IL-23 supports the maintenance and function of differentiated T H 17 cells. 15 Polarization of antigen-specific naive T cells into T H 1, T H 2, or T H 17 cells is a specialized function of migratory conventional dendritic cells (cDCs) derived from circulating pre-DCs. 3, 16 DCs also regulate effector T-cell responses because monocytederived dendritic cells (moDCs) control effector T-cell responses to allergens in the lungs as a result of the production of chemokines that attract effector cells to the lungs. 3, 17 DC activation is essential for proper T H cell differentiation into either T H 2 or T H 17 cells. 18 Activation of DCs in the context of asthma can occur directly by allergen exposure triggering pattern recognition receptors (PRRs) on DCs. 19, 20 In addition to direct activation, DCs are also activated by cytokines secreted by the airway epithelium on Toll-like receptor 4 ligation. 21 PRR triggering on DCs activates the transcription factor nuclear factor kB (NF-kB) and thereby initiates transcription of proinflammatory cytokines, such as IL-1 and IL-12. 22, 23 The activation threshold of DCs and NF-kB levels is carefully regulated because overt activation can lead to immune responses to self-antigens in addition to allergens. NF-kB activation is negatively regulated by TNF-a-induced protein 3 (TNFAIP3; also known as A20), a ubiquitin-modifying enzyme that deubiquitinates several key intermediate NF-kB signaling molecules and thus acts as a brake on DC activation. 24, 25 In particular, it has been shown that conditional deletion of TNFAIP3/A20 in macrophages or DCs (by using Cd11c-Creor lysozyme M [LysM]-Cre-mediated deletion in mice, respectively) results in increased phosphorylation and degradation of IkB. 25, 26 Genetic polymorphisms in TNFAIP3 and TNFAIP3 interacting protein (TNIP) have been associated with risk of asthma and allergies. 27, 28 How alterations in TNFAIP3 levels might control asthma development remains enigmatic because TNFAIP3 has very diverse effects in many different cell types. TNFAIP3 controls the production of T H cell-skewing cytokines in lung epithelial cells and a high expression (induced by environmental exposure to farm dust) is beneficial to protect from allergic asthma development. 27 Lack of TNFAIP3 in mast cells controls the activation state of the cell, causing increased plasma extravasation and features of eosinophilic asthma on allergen challenge. 29 The precise role of TNFAIP3 in myeloid cells in asthmatic patients is currently unknown; however, absence of TNFAIP3 in myeloid cells or CD11c hi DCs provokes T H 17 induction. 26 These studies indicate that TNFAIP3 levels in different cell types can control T H cell differentiation.
Because the role of TNFAIP3 in myeloid cells in the development of T H 2 immune responses is unknown at present, we addressed the precise role of TNFAIP3 in myeloid cells in the setting of asthma. To determine this, we used mice that lack Tnfaip3 in either myeloid cells or DCs and exposed these mice to either acute and chronic house dust mite (HDM)-driven asthma models. Our data show that TNFAIP3 levels in DCs control whether HDM induces a predominantly T H 2-mediated eosinophilic or T H 17-mediated neutrophilic form of the disease.
METHODS Mice

Tnfaip3
LysM and Tnfaip3 CD11c mice were bred and housed at Erasmus MC (Rotterdam, The Netherlands). Tnfaip3
LysM mice were crossed to ROSA26 fl EYFP mice, and Tnfaip3 CD11c mice were crossed to IL-23 YFP mice. 1-Der mice were provided by B. N. Lambrecht (VIB, Ghent, Belgium). Female C57BL/6 mice were from Harlan (Indianapolis, Ind). Experiments were performed on mice backcrossed onto the C57BL/6 genetic background for at least 10 generations and housed under specific pathogen-free conditions. Mice were analyzed at 6 to 12 weeks of age. All experiments were performed under approval of the animal ethics committee of the Erasmus MC.
HDM-induced allergic airway inflammation
During HDM exposures, mice were anesthetized with isoflurane. For the acute allergic HDM model, mice were sensitized intranasally with 1 mg/40 mL of HDM (Greer Laboratories, Lenoir, NC) or 40 mL of PBS (GIBCO Life Technologies; Grand Island, NY) as a control on day 1 and challenged on days 7 to 11 with 10 mg/40 mL of HDM. Mice were killed on day 15. In the chronic HDM-driven asthma model mice were treated intranasally with 25 mg/40 mL of HDM or 40 mL of PBS as a control 3 times per week for 5 consecutive weeks. 30 Mice were killed for analysis at day 37. Lung function was measured by using a whole-body plethysmograph (EMKA) under urethane sedation. Bronchoalveolar lavage (BAL) fluid was obtained by flushing the lungs 3 times with 1 mL of PBS containing 0.5 mmol/L EDTA (Sigma-Aldrich, St Louis, Mo). Lungs were inflated with either PBS/OCT (1:1) solution and placed in 4% paraformaldehyde and embedded in paraffin.
HDM-induced innate immune responses and T H cell polarization
HDM was labeled with Alexa Fluor 647 (Invitrogen, Molecular Probes, Waltham, Mass) to determine allergen uptake and migration by pulmonary DCs. Mice were treated intratracheally with 50 mg of HDM-Alexa Fluor 647 extract. Twenty-four and 72 hours later, allergen uptake was evaluated in pulmonary DC subsets, and migration was evaluated in DC subsets in the mediastinal lymph nodes (MLNs). Single-cell suspensions were obtained by digesting the lungs with DNAse and Liberase for 30 minutes at 378C. 3 On digestion, lungs were homogenized through a 100-mm cell strainer (BD Biosciences, San Jose, Calif). Red blood cells were lysed with osmotic lysis buffer (8.3% NH 4 CL, 1% KHCO 3 , and 0.04% NA 2 EDTA in Milli-Q; Millipore, Temecula, Calif).
Mice were treated intratracheally with 100 mg of HDM extract to determine the innate effect of HDM exposure on cytokine production by pulmonary DCs. Cytokine production was evaluated 24 hours later in pulmonary DC subsets.
To examine T H cell proliferation and differentiation in naive HDM-specific T cells, we adoptively transferred 2 3 10 6 carboxyfluorescein isothiocyanatelabeled 1-DER T cells specific to the Der p 1WAFSGVAAT peptide 30 before 50 mg of HDM extract. T H cell proliferation and differentiation were determined 3 days later by using flow cytometry.
Generation of bone marrow-derived DCs
To obtain moDCs, bone marrow (BM) cells were cultured for 9 days in DC culture medium: RPMI 1640 containing GlutaMAX (Invitrogen) supplemented with 5% FCS (Hyclone; GE Healthcare, Fairfield, Conn), 50 mmol/L 2-mercaptoethanol (Sigma-Aldrich), and 50 mg/mL gentamicin (Invitrogen) containing 20 ng/mL GM-CSF, as previously described. HDM (5 mg/mL) was added 18 hours before cell harvesting.
RNA sequencing
Total RNA was extracted from moDCs by using the miRNAeasy Mini Kit (Qiagen, Hilden, Germany). Approximately 1 mg of RNA from each sample was used to generate RNA sequencing (RNA-seq) cDNA libraries for sequencing with the TruSeq RNA Sample Prep Kit v2 (Illumina, San Diego, Calif). Sample preparation followed the manufacturer's protocol. Sequencing of SR42-bp paired reads was performed with an Illumina HiSeq HT instrument at the Bio Informatics department of the Erasmus MC. Single-end reads were aligned to the mouse genome (UCSC Genome Browser mm9) by using TopHat (version 2.0.8). Gene expression levels as fragments per kilobase of a transcript per million mapped reads were calculated by using Cufflinks.
RNA-seq data analysis
Differential gene expression assessment was done in the R environment (version 3.1.1) with edgeR software (version 3.6.8), 31 as described by Nota et al 32 on TIGR multiexperiment viewer (MeV) software. 33 MeV software was used to generate heat maps and principal component analysis. Canonical pathway analysis was performed with the MSigDB database.
Flow cytometry
Single-cell suspensions were prepared from BAL fluid and MLNs by using standard procedures. MLNs were homogenized through a 100-mm cell strainer (BD Biosciences). Flow cytometric surface and intracellular staining procedures have been described previously. 34 Monoclonal antibodies used for flow cytometric analyses are listed in Table E1 in this article's Online Repository at www.jacionline.org. For all experiments, dead cells were excluded with Live-Dead Aqua (Invitrogen). Cytokine production was measured by using flow cytometry. Cells were stimulated at 378C with 10 ng/mL phorbol 12-myristate 13-acetate (Sigma-Aldrich), 250 ng/mL ionomycin (Sigma-Aldrich), and GolgiStop (BD Biosciences) for 4 hours to measure cytokine production by T cells. Cells were stimulated at 378C with GolgiPlug (BD Biosciences) for 4 hours to measure cytokine production by DCs. Data were acquired with an LSR II flow cytometer (Becton Dickinson, Mountain View, Calif) and FACSDiva software (Becton Dickinson) and analyzed by using FlowJo software (version 9; TreeStar, Ashland, Ore).
Lung histology
Five-micrometer-thick paraffin-embedded lung sections were stained with hematoxylin and eosin.
ELISA
Antigen-specific IgE levels were measured in serum. Plates were coated overnight with anti-IgE capture antibody (OptEIA; BD Biosciences). Serum was incubated for 2 hours at 378C. Detection was performed with biotinylated HDM, and streptavidin-horseradish peroxidase was used to develop the ELISA, according to the manufacturer's protocol (OptEIA; BD Biosciences). IL-5 (Ready-Set-Go; eBioscience, San Diego, Calif), IL-13, IL-17 (R&D Systems, Minneapolis, Minn), and IFN-g (OptEIA; BD Biosciences) levels were measured in supernatants of HDM-restimulated MLN cells. Levels of IL-1b (OptEIA, BD Biosciences), IL-23, and IL-12p70 (Ready-Set-Go, eBioscience) were measured in supernatants of DC cultures 18 hours after HDM stimulation.
Statistical analysis
Mann-Whitney U tests were used for comparison between 2 groups, and a P value of less than .05 was considered statistically significant. RNA-seq analyses were performed with MeV software, and all other analyses were performed with Prism software (GraphPad Software, La Jolla, Calif).
RESULTS
LysM expression targets pulmonary DC subsets
Because the lysozyme M promotor is active in several myeloid cell types, 35 we crossed Tnfaip3 LysM mice to Rosa26-stop fl EYFP mice to visualize TNFAIP3 deletion in various myeloid cell types. As described before, yellow fluorescent protein (YFP) expression was found in pulmonary macrophages, neutrophils, monocytes, and DCs (Fig 1, A) . 35 LysM-driven Cre-recombinase activity in DCs has been reported previously 35 but is exceptional because cDCs seem to derive from a dedicated pre-cDC progenitor. 36, 37 Pulmonary DCs can be subdivided into cDCs (CD103 1 cDC1s and CD11b 1 cDC2s) and CD64 1 moDCs. 37 Both moDCs, cDC2s, and cDC1s showed similar YFP expression as pulmonary monocytes (Fig 1, B and C (Fig 1, A and C) . Not only did the proportions of YFP 1 cells increase, total DC, cDC1, and moDC numbers were increased in naive Tnfaip3
LysM-KO mice compared with both Tnfaip3
LysM-WT and Tnfaip3 LysM-HZ mice (Fig 1, D) . Ablation of TNFAIP3 in myeloid cells enhances NF-kB signaling, as indicated by increased phosphorylated IkB and increased expression of various costimulatory molecules, such as MHC class II, CD40, CD80, and CD86. 25 CD86 expression was evaluated in pulmonary DC subsets as a surrogate marker to examine NF-kB activation in vivo. Pulmonary DCs exhibited increased CD86 expression in Tnfaip3
LysM-HZ and Tnfaip3
LysM-KO mice compared with WT mice (Fig 1, E) , suggesting that both intermediate and absent TNFAIP3 expression influence DC activation. Reduced TNFAIP3 expression in DCs did not significantly influence antigen uptake and DC migration (see Fig E1, B) .
These data indicate that Cre-recombinase under the lysozyme M promotor not only deletes Tnfaip3 in macrophages, monocytes, and neutrophils but also targets pulmonary cDC subsets to a similar extent as monocytes. Absence of TNFAIP3 selectively increases numbers of cDC1s and moDCs, indicating that TNFAIP3 deletion in myeloid cells increases their recruitment or survival. Intermediate TNFAIP3 expression already influences DC numbers and activation status.
Myeloid-specific deletion of Tnfaip3 induces T H 17-mediated neutrophilic airway inflammation in an HDM-driven model
To address whether TNFAIP3 expression in myeloid cells controls asthma development, we used Tnfaip3
LysM mice 26 and exposed them to an acute HDM-driven asthma model (Fig 2, A) . As expected, HDM-sensitized Tnfaip3
LysM-WT mice had increased eosinophil numbers in BAL fluid compared with PBS-treated control mice (Fig 2, C) . In contrast, HDM-sensitized Tnfaip3
LysM-KO mice had only very mild eosinophilic inflammation, but neutrophilic inflammation was increased compared with that in WT control mice. Moreover, by using Tnfaip3
LysM-HZ mice, a gene dose effect was observed because these mice had mixed eosinophilic/neutrophilic inflammation (Fig 2, C) . T-cell, B-cell, DC, and macrophage influx did not differ between Tnfaip3
LysM-WT and Tnfaip3 LysM-KO mice, yet B-cell numbers were increased in HDM-sensitized Tnfaip3
LysM-HZ mice compared with HDM-sensitized Tnfaip3
LysM-WT and Tnfaip3 LysM-KO mice (Fig 2, D and E) .
Eosinophilia is generally associated with a type 2 immune response, whereas neutrophilia is a sign of IL-17-producing cells. Whereas numbers of IL-5-and IL-13-expressing T H 2 cells were increased in BAL fluid of HDM-sensitized Tnfaip3
LysM-WT mice, Tnfaip3
LysM-KO mice mainly showed an increase in numbers of IL-17-expressing T H 17 and IFN-g-expressing T H 1 cells (Fig 2, 
org). IL-17/IFN-g double-expressing CD4 T cells were not induced (data not shown). Tnfaip3
LysM-HZ mice had increased numbers of T H 2 cells compared with Tnfaip3
LysM-WT and Tnfaip3 LysM-KO mice and similar numbers of T H 17 cells compared with Tnfaip3
LysM-KO mice (Fig 2, F) . Effector T cells are typically found in the lungs, whereas central memory T cells are found in lung draining MLNs. IL-17 and IFN-g secretion were also increased in in vitro HDMrestimulated MLN cells of HDM-sensitized Tnfaip3
LysM-WT and Tnfaip3
LysM-HZ mice. IL-13 levels were increased in in vitro HDM-restimulated MLN cells of HDM-sensitized Tnfaip3 LysM-HZ mice compared with HDM-sensitized Tnfaip3
LysM-WT mice (Fig 2, G) . In summary, ablation of TNFAIP3 levels in myeloid cells induces neutrophilic T H 17-associated airway inflammation rather than T H 2-associated eosinophilic airway inflammation in an HDM-driven airway inflammation model. Strikingly, intermediate TNFAIP3 expression in myeloid cells increased both the T H 2 and T H 17 response after HDM exposure.
Tnfaip3
LysM-KO mice experience severe asthma on chronic HDM exposure Patients with uncontrolled severe asthma have increased neutrophil numbers, increased IL-17 levels in serum and BAL fluid, and increased airway remodeling. 38 To more closely mimic severe asthma and to induce structural airway remodeling in mice, we exposed Tnfaip3 LysM mice to HDM over a period of 5 weeks (Fig 3, A) . 39 On chronic HDM exposure, eosinophilic and B-cell inflammation were increased in both Tnfaip3
LysM-KO mice compared with PBS control values. Neutrophils and total T-cell numbers were higher in HDM-treated Tnfaip3
LysM-KO mice compared with HDM-treated Tnfaip3
LysM-WT mice (Fig 3, C and D) . No differences were found in T H 2 cell numbers in BAL fluid of Tnfaip3
LysM-WT and Tnfaip3 LysM-KO mice, whereas T H 17 and T H 1 cell numbers were strongly increased in Tnfaip3
LysM-WT mice (Fig 3,  E) .
Serum levels of HDM-specific IgE were similar between HMD-treated Tnfaip3
LysM-KO mice (Fig 3, F) . Keratinocyte chemoattractant (KC) levels in BAL fluid were only induced in HDM-treated Tnfaip3
LysM-KO mice (Fig 3, G) . HDM-treated Tnfaip3 LysM-KO mice showed denser pulmonary inflammatory sites compared with HDMtreated Tnfaip3
LysM-WT mice (Fig 3, H) . Lung resistance was even higher in HDM-treated Tnfaip3
LysM-KO mice compared with HDM-exposed Tnfaip3
LysM-WT mice (Fig 3, I) . Surprisingly, LysM-HZ , and Tnfaip3 LysM-KO mice. D, Quantification of total DCs, cDC1s, cDC2s, and moDCs by using flow cytometry. E, Quantification of CD86 mean fluorescent intensity (MFI) of lung DC subsets by using flow cytometry. Results are presented as means 6 SEMs of 3 to 4 mice per group and representative of 2 or more independent experiments. *P < .05.
no differences in IL-13-expressing CD4
1 T cells were observed between HDM-exposed Tnfaip3
LysM-KO mice, a key cytokine for increased airway hyperresponsiveness (AHR).
In conclusion, on chronic HDM exposure, the absence of TNFAIP3 in myeloid cells induces development of a severe T H 2/T H 17 cell-associated eosinophilic and neutrophilic asthma phenotype with increased lung resistance. 
DC-specific deletion of Tnfaip3 also induces T H 17-mediated neutrophilic asthma
As shown before, deletion of Tnfaip3 with the LysM promotor affected many cell types, including neutrophils, that accumulated in the airways of Tnfaip3
LysM-KO mice after HDM challenge.
To specify whether reduced TNFAIP3 levels only in CD11c hi DCs were responsible for the development of T H 17-mediated neutrophilic asthma phenotype, we exposed Tnfaip3 CD11c mice to the acute HDM-driven asthma protocol (Fig 2, A) . In these mice Tnfaip3 is specifically deleted in all DC subsets and alveolar 
Tnfaip3
LysM-WT PBS
LysM-WT HDM
LysM-KO PBS
LysM-KO HDM analyzed by using flow cytometry. F, Serum HDM-specific IgE levels. G, BAL fluid levels of KC measured by using ELISA. H, Histologic analysis of lung inflammation by means of hematoxylin and eosin staining. I, Bronchial hyperresponsiveness was measured on increasing doses of inhaled methacholine. Results are presented as means 6 SEMs of 3 to 5 mice per group and representative of 2 or more independent experiments. *P < .05 and **P < .01.
BAL Eosinophils
macrophages, as previously shown by Kool et al. 25 Pulmonary cDC subsets are decreased in Tnfaip3 
org). In contrast, moDCs are increased in naive Tnfaip3
CD11c-KO mice compared with Tnfaip3 CD11c-WT mice (see Fig E3) . HDM-sensitized Tnfaip3
CD11c-KO mice were resistant to development of eosinophilic inflammation, yet a strong neutrophilic inflammation was induced compared with that in HDM-sensitized WT control animals. Like Tnfaip3
LysM-HZ mice, HDM-treated Tnfaip3 CD11c-HZ mice had a mixed eosinophilic/neutrophilic inflammation (Fig 4, A and B) . Numbers of T cells and macrophages in BAL fluid were not significantly different between HDM-sensitized Tnfaip3
CD11c-HZ , and Tnfaip3 CD11c-KO mice, but B-cell and DC numbers were reduced in HDM-sensitized Tnfaip3
CD11c-KO mice compared with both HDM-sensitized
Tnfaip3
CD11c-WT and Tnfaip3 CD11c-HZ mice (Fig 4, C and D) . T H 2 cell numbers in BAL fluid of HDM-sensitized Tnfaip3
CD11c-WT and Tnfaip3 CD11c-HZ mice were increased compared with those in HDM-sensitized Tnfaip3
CD11c-KO mice (Fig 4, E, and see Fig E2, B) . HDM-sensitized Tnfaip3
CD11c-KO mice showed increased T H 17 cell numbers in BAL fluid compared with those in HDM-sensitized Tnfaip3
CD11c-WT mice (Fig 4, E) . MLN cells of both HDM-sensitized Tnfaip3
CD11c-WT and Tnfaip3
CD11c-HZ mice produced an IL-13 in response to HDM restimulation in vitro, whereas no IL-13 production was found in HDM-restimulated MLN cells of HDMsensitized Tnfaip3
CD11c-KO mice. IL-17A levels were higher in HDM-restimulated MLN cells of HDM-sensitized Tnfaip3
CD11c-KO mice than of HDM-sensitized Tnfaip3
CD11c-WT mice (Fig 4, F) . Therefore we conclude that specific ablation of TNFAIP3 in CD11c hi DCs (and/or alveolar macrophages) but not in 
Instruction of T H 17 differentiation of HDM-specific T cells by Tnfaip3-deficient DCs
To investigate more directly whether Tnfaip3 CD11c-KO mice induced HDM-specific T H 17 differentiation, Tnfaip3
CD11c mice received Der p 1-specific T-cell receptor (TCR) transgenic
CD4
1 T cells obtained from 1-DER mouse intravenously.
1-DER CD4
1 T cells express a transgenic TCR encoding a Vb4 and Va8 chain, leading to a precursor frequency of 60% to 70% of Der p 1-reactive CD4 1 T cells. 30 On day 0, carboxyfluorescein isothiocyanate-labeled 1-DER CD4 1 T cells were transferred into Tnfaip3 CD11c mice to determine their proliferative capacity. Tnfaip3
CD11c mice were subsequently treated intratracheally with 50 mg of HDM at day 1 (Fig 5, A) . At day 4, 1-DER T cells that were transferred into J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 5
Tnfaip3
CD11c-KO mice showed reduced proliferation in MLNs compared with those transferred into Tnfaip3
CD11c-WT and Tnfaip3
CD11c-HZ mice (Fig 5, B and C) . However, the replication index in the dividing 1-DER T cells in Tnfaip3
CD11c-HZ and Tnfaip3 CD11c-KO mice was increased compared with that in dividing 1-DER T cells in Tnfaip3
CD11c-WT mice (Fig 5, D) . This indicates that once 1-DER T cells start proliferation, the number of proliferation cycles is greater in Tnfaip3
CD11c-KO mice compared with that in Tnfaip3
CD11c-WT mice. Expression of lineage-defining transcription factors, such as retinoic acid receptor-related orphan receptor gt, GATA-3, and T-box transcription factor (T-bet), was used to study differentiation of T H 17, T H 2, and T H 1 cells, respectively. Strikingly, the percentage of retinoic acid receptor-related orphan receptor gt-positive 1-DER T cells was increased in both undivided and divided 1-DER T-cells in Tnfaip3
CD11c-KO mice compared with that in both Tnfaip3
CD11c-HZ mice (Fig 5, E and F) . The mean fluorescent intensity of GATA-3 and T-bet was increased in divided 1-DER T cells compared with that in undivided 1-DER T cells in all mice; however, both undivided and divided 1-DER T cells in Tnfaip3
CD11c-KO mice had decreased levels of GATA-3 compared with Tnfaip3
CD11c-WT and Tnfaip3 CD11c-HZ mice (Fig 5, F) . No differences were found in expression levels of T-bet in 1-DER T cells in Tnfaip3
CD11c-HZ , and Tnfaip3
CD11c-KO mice (Fig 5, F) .
This indicates that HDM induces T H 17 cell differentiation of Der p 1-specific T cells in Tnfaip3
CD11c-KO mice that lack TNFAIP3 expression in DCs and alveolar macrophages, whereas in WT mice it predominantly induces a T H 2 response.
Adoptive transfer of Tnfaip3-sufficient or deficient DCs drives eosinophilic or neutrophilic asthma
The Cd11c promotor used to excise Tnfaip3 can also lead to excision of this gene in other cells, such as alveolar macrophages, CD8 T cells, plasmacytoid DCs, and plasmablasts, caused by Cd11c gene expression in these cell types. 40 Therefore we resorted to a model of intratracheal adoptive transfer of BM-derived DCs to induce asthma. 41 This would exclude any effects caused by expression outside of the DC lineage. It became clear that GM-CSF-stimulated BM cultures contain a mix of cDCs and macrophage-like cells, but we did not observe large shifts in the relative distribution of these cell subsets in cultures of mice of different genotypes (see Fig E4 in CD11c-WT and Tnfaip3 CD11c-KO mice, followed by 5 HDM challenges (Fig 6, A) . C57BL/6 mice sensitized with HDM-stimulated Tnfaip3
WT DCs or Tnfaip3 HZ DCs had increased eosinophilic airway inflammation both in absolute numbers and percentages compared with mice sensitized with PBS-stimulated Tnfaip3
WT DCs (Fig 6, B) 
11
HDM i.n. A, C57bl/6 mice were sensitized on day 1 intranasally (i.n.) with 30.000 PBS/HDM-stimulated GM-CSFcultured DCs from BM of Tnfaip3 CD11c mice. All mice were challenged intranasally with 10 mg/d HDM between days 7 and 11 to induce allergic asthma. Analysis was performed at day 15. B and C, Quantification of total BAL inflammation, eosinophils, and neutrophils by using flow cytometry. (Fig 6, D) . Furthermore, in vitro coculture of antigen-pulsed Tnfaip3 KO DCs with antigen TCR-specific CD4
BAL Eosinophils
1 T cells showed that Tnfaip3 KO DCs induced IL-17 production by T H cells in contrast to T H 2 differentiation by Tnfaip3
WT DCs (see Fig E6, A, in this article's Online Repository at www.jacionline.org). IL-17 production was specifically induced by GM-CSF-cultured BM-derived DCs and not by FLt3L-cultured cDC1s, cDC2s, or plasmacytoid DCs (see Fig E6, B) .
In conclusion, TNFAIP3 deletion dose dependently induced T H 17 differentiation while hampering T H 2 differentiation, resulting in an absence of eosinophilic inflammation in mice sensitized with Tnfaip3-deficient DCs.
Tnfaip3
KO DCs display a pro-T H 17 cell signature on HDM stimulation in vitro and in vivo
To gain insight into the mechanism by which Tnfaip3 KO DCs induced T H 17 cell differentiation, we performed gene expression profiling of PBS-or HDM-stimulated GM-CSF BM-cultured Tnfaip3
WT and Tnfaip3 KO DCs. Both unstimulated and HDM-stimulated GM-CSF BM-cultured Tnfaip3
WT and
Tnfaip3
KO DCs differed in their expression profile, as observed in the principal component analysis (Fig 7, A) (Fig 7, B) 43 Furthermore, IL-12b, a cytokine known to inhibit T H 2 differentiation when expressed in DCs, 44 was specifically induced in HDM-stimulated Tnfaip3 KO DCs (Fig 7, C and D) . IL-1b, IL-23, and IL-12 protein expression in culture supernatants of BM-derived DC cultures was also increased on HDM stimulation, whereas IL-6 protein expression was already increased in unstimulated GM-CSF BM-cultured Tnfaip3 KO DCs compared with HDM-stimulated GM-CSF BM-cultured Tnfaip3
WT DCs (Fig 7, E) . HDM-exposed Tnfaip3 HZ DCs showed an intermediate production of most cytokines compared with Tnfaip3
WT DCs and Tnfaip3 KO DCs (Fig 7, E) .
Because GM-CSF-cultured DCs displayed a T H 17 cellpromoting phenotype on HDM stimulation in vitro, we wondered whether T H 17 cell differentiation of instructive cytokines would also be increased in DCs of Tnfaip3
CD11c mice that received HDM in vivo. To determine this, IL-23 YFP mice were crossed to Tnfaip3 CD11c-KO mice were increased compared with those in IL-23
CD11c-WT mice (Fig 8) . cDC2s in IL-23   YFP   xTnfaip3 CD11c-KO mice had significantly increased IL-23 production, whereas IL-6 and IL-23 production was not different between cDC1s in IL-23
CD11c-WT and IL-23
CD11c-KO mice (Fig 8, B) . In summary, these data show that Tnfaip3-deficient moDCs and cDC2s express increased levels of cytokines that promote T H 17 differentiation in response to HDM.
DISCUSSION
Asthma is a heterogeneous disorder. Patients with mild-tomoderate asthma often display T H 2 cell-mediated eosinophilic inflammation, whereas patients with severe asthma often present with T H 17 cell-mediated neutrophilic inflammation.
1 DCs are essential for both the initiation and maintenance of T H 2 cell-mediated asthma and can also induce pulmonary T H 17 cell responses. 3, 45 However, the underlying mechanisms driving T H 17 cell-driven neutrophilic asthma are still undetermined. We and others have previously shown that DC activation is crucial for T H cell differentiation and activation and is mediated through NF-kB activation driving expression of key cytokine pathways. Ablating the negative feedback regulator of NF-kB signaling, TNFAIP3, in myeloid cells and DCs was shown to be essential for T H 17 differentiation. 25, 26 Our results demonstrate that TNFAIP3 levels in DCs control the development of T H 17 cell-mediated neutrophilic asthma in an acute HMD-driven asthma model and mixed T H 2/T H 17-mediated severe eosinophilic/neutrophilic asthma in a chronic HDM-driven asthma model. TNFAIP3-deficient DCs induced HDM-specific T H 17 cell differentiation and hampered HDM-specific T H 2 cell differentiation. TNFAIP3 deficiency in DCs does not affect their capability to take up allergens and migrate toward the lymph nodes, but it does affect the number of DC subsets. TNFAIP3-deficient cDC2s and moDCs produce cytokines implicated in T H 17 cell differentiation, such as IL-1b, IL-6, and IL-23. 46 Furthermore, both increased IL-12 and IL-6 by TNFAIP3-deficient DCs could hamper T H 2 immunity. 43 ,44 IL-6 inhibits T H 2 immunity either directly by inhibiting GATA-3 expression or indirectly by restricting IL-4 expression by follicular T H cells. 47 IL-12 strongly promotes T H 1 differentiation and thereby hampers T H 2 differentiation. 43 Ablating TNFAIP3 expression in DCs increased AHR on chronic exposure to HDM, whereas levels of the AHR-inducing cytokine IL-13 was similar between knockout and WT mice; however, IL-17 levels are specifically increased in mice lacking TNFAIP3 in DCs. Transfer of both T H 2 and T H 17 cells has been shown to elicit AHR, 48 suggesting that combined expression of T H 2 and T H 17 cell cytokines further enhances AHR. Furthermore, suppression of IL-13 and IL-17 simultaneously decreases AHR more efficiently. 49 Blockade of IL-17A during the chronic HDM protocol restored neutrophil inflammation in Tnfaip3
LysM-KO mice to similar neutrophil numbers as observed in Tnfaip3
LysM-WT mice (data not shown), which could suggest that AHR also depends on IL-17A in our model. Tnfaip3 LysM-KO mice have mild eosinophilic inflammation on HDM sensitization, which is completely absent in Tnfaip3
CD11c-KO mice. Differences in eosinophilic inflammation between these 2 transgenic mouse strains is probably mediated by different induction of IL-5-producing CD4
1 T cells, which were present in Tnfaip3
LysM-KO mice and entirely lacking in Tnfaip3
CD11c-KO mice (see Fig E2) . The different T H 2 cell induction could be caused by the different percentage of DCs targeted for TNFAIP3 deletion in Tnfaip3
LysM and Tnfaip3
CD11c
mice. LysM-Cre targets 40% to 60% of the DC subsets for Tnfaip3 deletion (Fig 1) , whereas CD11c-Cre excises TNFAIP3 in 90% to 100% of all DC subsets. 50 In addition to controlling NF-kB activation, TNFAIP3 also regulates apoptosis susceptibility. 51 Our deep sequencing data showed that TNFAIP3 deficiency does not affect survival pathways in cultured moDCs; however, cDC1s and cDC2s could be differently susceptible. In support, 90% to 100% deletion of TNFAIP3 using CD11c-Cre impairs the number of pulmonary cDC1s and cDC2s, whereas no alterations in cDC1 and cDC2 numbers were observed in LysM-Cre mice.
Sensitization of C57BL/6 mice with TNFAIP3-deficient DCs also induced T H 17 cell differentiation, suggesting that our observed phenotype was indeed due to genetic alterations selectively in DCs and not neutrophils.
Our data indicate that TNFAIP3 levels directly control secretion of T H 17-polarizing cytokines in moDCs and cDC2s both in vivo and in vitro, whereas levels of these cytokines are not increased in cDC1s. This, together with the fact that cDC2s and moDCs are essential for T H 2 differentiation and maintenance in asthma, 3 shows that these DC subsets are crucial for the balance of T H 2/T H 17 cell differentiation in lungs of asthmatic patients.
Ablation of TNFAIP3 in DCs results in constitutive NF-kB activation. 25, 52 NF-kB directly promotes transcription of the proinflammatory T H 17 differentiation target genes IL1B and IL6, 53 which indicates that TNFAIP3 deletion in DCs directly enables transcription of T H 17-promoting cytokines through increased NF-kB signaling.
It is conceivable that environmental triggers might also alter Tnfaip3 expression in DCs because combined exposure to allergens and environmental factors (eg, diesel exhaust particles, cigarette smoke, and viral infections) are essential for DC-induced T H 17-mediated severe asthma through induction of T H 17 cell-differentiating cytokines. 18, 54 Thus it will be very important to study whether any of these environmental coregulators can suppress TNFAIP3 gene and/or protein LysM mice. *P < .05.
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 5 expression in DCs. There is already evidence for such environmental regulation of TNFAIP3 in lung epithelial cells in vivo. 27 TNFAIP3 seems to be strongly regulated by microRNAs (mir125 family and mir221), 55 and microRNA levels can vary greatly in response to chronic environmental stimulation.
In conclusion, our data demonstrate that loss of TNFAIP3, specifically in pulmonary cDC2s and moDCs, amplifies NF-kBcontrolled gene expression of IL-6 and IL-23 in response to allergen exposure. Increases in these T H 17 cell-polarizing cytokines promote T H 17 cell differentiation and the T H 17 cell-mediated severe neutrophilic asthma phenotype accompanied by increased lung resistance. As a result, our data imply that increasing TNFAIP3 levels and thereby decreasing DC activation could be a new pharmacologic intervention to treat severe T H 17 cell-mediated neutrophilic asthma. 
